Cargando…

Assessment of Patient Experiences with Respimat(®) in Everyday Clinical Practice

INTRODUCTION: Chronic obstructive pulmonary disease (COPD) is a progressive disease requiring maintenance therapy. According to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) strategy report, bronchodilation with long-acting muscarinic antagonists (LAMAs) and long-acting β(2)-agon...

Descripción completa

Detalles Bibliográficos
Autores principales:	Taube, Christian, Bayer, Valentina, Zehendner, Christoph Michael, Valipour, Arschang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2020
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7671953/ https://www.ncbi.nlm.nih.gov/pubmed/32857327 http://dx.doi.org/10.1007/s41030-020-00127-4

Ejemplares similares

Modern Bronchoscopic Treatment Options for Patients with Chronic Bronchitis
por: Mayr, Anna Katharina, et al.
Publicado: (2023)

Assessment of physical functioning and handling of tiotropium/olodaterol Respimat(®) in patients with COPD in a real-world clinical setting
por: Steinmetz, Karl-Otto, et al.
Publicado: (2019)

Reduced Environmental Impact of the Reusable Respimat(®) Soft Mist™ Inhaler Compared with Pressurised Metered-Dose Inhalers
por: Hänsel, Michaela, et al.
Publicado: (2019)

An Observational Study Assessing Changes in Health and Functional Status in Patients with Chronic Obstructive Pulmonary Disease (COPD) During Therapy with Spiolto(®) Respimat(®) in Everyday Clinical Practice: The Greek ELLACTO Study
por: Kosmas, Epaminondas, et al.
Publicado: (2021)

Therapeutic Success of Tiotropium/Olodaterol, Measured Using the Clinical COPD Questionnaire (CCQ), in Routine Clinical Practice: A Multinational Non-Interventional Study
por: Valipour, Arschang, et al.
Publicado: (2021)

Laparoscopic Surgery with Concomitant Hernia Repair and Cholecystectomy: An Alternative Approach to Everyday Practice
por: Zarogoulidis, Paul, et al.
Publicado: (2023)

Treatment of persistent COVID-19 in two B-cell-depleted patients with the monoclonal antibody Sotrovimab
por: Totschnig, David, et al.
Publicado: (2022)

Concreteness and abstraction in everyday explanation
por: Bechlivanidis, Christos, et al.
Publicado: (2017)

Use of Respimat(®) Soft Mist™ Inhaler in COPD patients
por: Anderson, Paula
Publicado: (2006)

If the clinical experience is very important for everyday practice…
por: Wróblewski, Tadeusz
Publicado: (2015)

Swiss Experience in Therapy With Dual Bronchodilation in Chronic Obstructive Pulmonary Disease in Relation to Self-Reported Physical Functionality
por: Spielmanns, Marc, et al.
Publicado: (2021)

Tiotropium HandiHaler(®) and Respimat(®) in COPD: a pooled safety analysis
por: Halpin, David MG, et al.
Publicado: (2015)

Asthma patients prefer Respimat(®) Soft Mist™ Inhaler to Turbuhaler(®)
por: Hodder, Rick, et al.
Publicado: (2009)

“Nitrogen Wash-Out” in Non-Hypoxaemic Patients with Spontaneous Pneumothorax: A Narrative Review
por: Grasmuk-Siegl, Erwin, et al.
Publicado: (2023)

Physical Functioning in Patients with Chronic Obstructive Pulmonary Disease Treated with Tiotropium/Olodaterol Respimat in Routine Clinical Practice in Italy
por: Carone, Mauro, et al.
Publicado: (2020)

Everyday Parameters for Episode‐to‐Episode Dynamics in the Daily Music of Infancy
por: Mendoza, Jennifer K., et al.
Publicado: (2022)

Improvement In Self-Reported Physical Functioning With Tiotropium/Olodaterol In Central And Eastern European COPD Patients
por: Valipour, Arschang, et al.
Publicado: (2019)

Chronic obstructive pulmonary disease phenotypes: imprint on pharmacological and non-pharmacological therapy
por: Bakeer, Mostafa, et al.
Publicado: (2020)

Development of Respimat(®) Soft Mist™ Inhaler and its clinical utility in respiratory disorders
por: Dalby, Richard N, et al.
Publicado: (2011)

Patients’ perspectives and preferences in the choice of inhalers: the case for Respimat(®) or HandiHaler(®)
por: Dekhuijzen, Pieter Nicolaas Richard, et al.
Publicado: (2016)

The Respimat(®) Soft Mist Inhaler: Implications of Drug Delivery Characteristics for Patients
por: Iwanaga, Takashi, et al.
Publicado: (2019)

Patient preferences for inhaler devices in chronic obstructive pulmonary disease: experience with Respimat(®) Soft Mist(™) Inhaler
por: Hodder, Richard, et al.
Publicado: (2009)

Vaccination against SARS-CoV-2 in adults with a diagnosis of cancer: a short review
por: Huf, Waltraud Elisabeth, et al.
Publicado: (2023)

Cardiovascular safety of tiotropium Respimat vs HandiHaler in the routine clinical practice: A population-based cohort study
por: Trotta, Francesco, et al.
Publicado: (2017)

Organizing pneumonia following Covid19 pneumonia
por: Funk, Georg-Christian, et al.
Publicado: (2021)

The Tiotropium Safety and Performance in Respimat® (TIOSPIR®) Trial: Spirometry Outcomes
por: Anzueto, Antonio, et al.
Publicado: (2015)

Tiotropium Respimat(®) Versus HandiHaler(®): Comparison of Bronchodilator Efficacy of Various Doses in Clinical Trials
por: Calverley, Peter M. A., et al.
Publicado: (2016)

EVELUT®: A Real-World, Observational Study Assessing Dyspnoea and Symptom Burden in COPD Patients Switched from LABA/ICS to LAMA/LABA or LAMA/LABA/ICS
por: Buhl, Roland, et al.
Publicado: (2023)

Feasibility and Acceptability of Telemedicine to Substitute Outpatient Rehabilitation Services in the COVID-19 Emergency in Italy: An Observational Everyday Clinical-Life Study
por: Negrini, Stefano, et al.
Publicado: (2020)

Clinical Practice of Gastrointestinal Endoscopy in COVID-19 Patients: An Experience from Indonesia
por: Pribadi, Rabbinu Rangga, et al.
Publicado: (2022)

Tiotropium Respimat® improves physical functioning in chronic obstructive pulmonary disease
por: Rau-Berger, Heike, et al.
Publicado: (2010)

Safety and efficacy of tiotropium in patients switching from HandiHaler to Respimat in the TIOSPIR trial
por: Dahl, Ronald, et al.
Publicado: (2015)

A Non-Interventional Study of Tiotropium/Olodaterol versus Any Triple Combination Therapy for Chronic Obstructive Pulmonary Disease: The EVELUT(®) Study Protocol
por: Buhl, Roland, et al.
Publicado: (2020)

Therapeutic Success in Swiss COPD Patients Receiving Dual Bronchodilation Therapy as COPD Maintenance Treatment
por: Spielmanns, Marc, et al.
Publicado: (2022)

Cognitive functioning in everyday life: The development of a questionnaire on instrumental activities of daily living in multiple sclerosis
por: van Dam, Maureen, et al.
Publicado: (2021)

A randomised dose-ranging study of tiotropium Respimat® in children with symptomatic asthma despite inhaled corticosteroids
por: Vogelberg, Christian, et al.
Publicado: (2015)

The experience and awareness of laparoendoscopic procedures among Polish surgeons in everyday clinical practice
por: Mitura, Kryspin, et al.
Publicado: (2017)

MELANCHOLIA IN EVERYDAY PRACTICE
Publicado: (1935)

Insanity in Everyday Practice
Publicado: (1918)

Increased brachial intima-media thickness is associated with circulating levels of asymmetric dimethylarginine in patients with COPD
por: Urban, Matthias Helmut, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_n3bh09nai394ok9k0ktvvrc5vf